Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
KRAS wild-type Metastatic Colorectal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Non-Small Cell Lung Cancer.
Testicular, Ovarian, Bladder, Lung, Colorectal, Gastric, and Head & Neck Cancers.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Prevention and treatment of chemotherapy-induced febrile neutropenia and hematopoietic recovery.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Targeted treatment of solid tumors and hematologic malignancies.
HER2-overexpressing Breast Cancer, metastatic Gastric Cancer, and gastroesophageal junction adenocarcinoma.
HER2-overexpressing Breast Cancer, metastatic Gastric Cancer, and gastroesophageal junction adenocarcinoma.